跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CREON MINIMICROSPHERES 35 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CREON MINIMICROSPHERES 35
Authorized
STANDARD
CREON MINIMICROSPHERES 35
BGP Pharma ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e814f0bff4de37e4
Company
BGP Pharma ULC
Type
Standard
Approval Details
Approval Id
e814f0bff4de37e4
Drug Approval Canada Name
CREON MINIMICROSPHERES 35
Product Name
CREON MINIMICROSPHERES 35
Status
Marketed
Status Date
2021-01-26
Original Market Date
2021-01-26
Din
02494639
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:16.00
Atc Original
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Atc Name
a 09 aa 02
Aig Number
0302964045
Company Name
BGP Pharma ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
AMYLASE
35700 UNIT
LIPASE
35000 UNIT
PROTEASE
2240 UNIT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e814f0bff4de37e4
Type
Standard
Back to Health Canada Approvals